[Progress in diagnosis of and therapy for diabetic cranial neuropathies].
Okamoto
Koichi
K
D000527:Alprostadil / Q000627:therapeutic use; D003389:Cranial Nerve Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003937:Diagnosis, Differential; D005158:Facial Paralysis / Q000209:etiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000857:Olfaction Disorders / Q000209:etiology; D009886:Ophthalmoplegia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D009901:Optic Nerve Diseases / Q000209:etiology; D020433:Trigeminal Nerve Diseases / Q000209:etiology
D007004:Hypoglycemic Agents; D000527:Alprostadil